Anson Funds Management LP Eloxx Pharmaceuticals, Inc. Transaction History

Anson Funds Management LP

  • $663 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$0.4 - $0.72 $221,460 - $398,629
-553,652 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$0.62 - $1.61 $343,264 - $891,379
553,652 New
553,652 $391,000

About Eloxx Pharmaceuticals, Inc.

ELOX Quotes by TradingView
  • Ticker ELOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,656,200
  • Description
  • Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...
More about ELOX
Track This Portfolio

Track Anson Funds Management LP Portfolio

Follow Anson Funds Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Anson Funds Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email